Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis - Wikidata - awgldk - TriplyDB

Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

http://www.wikidata.org/entity/Q28607750

about

A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease.Promising therapies for treatment of nonalcoholic steatohepatitis.Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.Clinical guidelines of non-alcoholic fatty liver disease: A systematic review.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease.Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice.Glycosylation site occupancy in health, congenital disorder of glycosylation and fatty liver disease.Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease.A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis.Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice.Metabolic syndrome increases dietary α-tocopherol requirements as assessed using urinary and plasma vitamin E catabolites: a double-blind, crossover clinical trial.Metabolic Syndrome is Associated with Health-Related Quality of Life in Suspected Patients with Nonalcoholic Steatohepatitis.Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation.Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings from a Multi-ethnic Cohort.Exenatide induces carcinoembryonic antigen-related cell adhesion molecule 1 expression to prevent hepatic steatosis.Acute loss of iron-sulfur clusters results in metabolic reprogramming and generation of lipid droplets in mammalian cells.Diagnostic accuracy of point shear wave elastography and transient elastography for staging hepatic fibrosis in patients with non-alcoholic fatty liver disease: a meta-analysis The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)

P2860

Q28074377-C10761FC-38D9-4135-A71F-3215130A04CE Q30248578-4ADB3396-0E0B-4BDD-A648-A259A59ED940 Q30355082-01C5D077-9BC7-4BCB-9F17-C1E6DCFCF01A Q31171499-6276A29A-0B21-49EB-BF67-A648BA7FD6D6 Q35989613-2E151C17-4EEE-4088-A03A-4E55B78A7BFC Q36952218-21E7323B-68B7-450B-9DBF-2AA2898D4403 Q37284519-96072D92-50B5-4E87-81DA-8439B3BE3BCB Q38641190-E17560A7-CFF6-428C-B197-231A14363751 Q38685245-FDB3EF1E-F6EB-4491-843C-5CD3E02CA70F Q38802973-3F85DBA0-EAEB-49FB-B798-208264DF3F19 Q38867829-CD064F03-4161-46AD-BE21-9B60890FE001 Q41388809-EF0885C6-8E52-4568-AF43-36C70F204886 Q41706840-01F030C9-3632-4BFB-82A1-A16F351132F9 Q41761865-F6F07954-45A3-4F37-B532-C0143F08B0E4 Q42286100-2C7C5257-7E54-429E-A40A-93BDA62152B7 Q48362689-87E997F0-D44E-4C50-8761-6A5AE45D9E54 Q50198326-493F1066-FC06-426F-BD85-A028AB4D947D Q51176303-ECD50F6F-3D52-4768-9185-4F62AD081DCF Q52582972-E6F0204A-45CC-4041-B5AB-1D72F30C39F8 Q54941250-12875C84-DE8A-4C55-A432-07832DE5A5DF Q55078174-25ED6B76-D1BB-4417-ABD1-597ACCC667EE Q58713138-D4B669CC-FF22-47E1-941E-B2C410E7DA9F Q58726261-EB70B790-DD70-4E8D-BA96-1ECCEC793053

P2860

Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

http://www.wikidata.org/entity/Q28607750

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Recommendations for Diagnosis, ...... d Nonalcoholic Steatohepatitis

@ast

Recommendations for Diagnosis, ...... d Nonalcoholic Steatohepatitis

@en

Recommendations for Diagnosis, ...... d Nonalcoholic Steatohepatitis

@nl

type

label

Recommendations for Diagnosis, ...... d Nonalcoholic Steatohepatitis

@ast

Recommendations for Diagnosis, ...... d Nonalcoholic Steatohepatitis

@en

Recommendations for Diagnosis, ...... d Nonalcoholic Steatohepatitis

@nl

prefLabel

Recommendations for Diagnosis, ...... d Nonalcoholic Steatohepatitis

@ast

Recommendations for Diagnosis, ...... d Nonalcoholic Steatohepatitis

@en

Recommendations for Diagnosis, ...... d Nonalcoholic Steatohepatitis

@nl

P1433

Q28607750-C6E397A4-8141-441A-9DEB-C0D7F1E3BC60

P1476

Q28607750-F0965D92-48A5-47CF-92D0-94B7E46435E5

P2093

Q28607750-0CEF0F96-2308-41F4-930B-5D069E75B439

Q28607750-5039C4B3-3BFB-4F7F-A1EC-5C616EB6D58E

P2860

Q28607750-0520AC3C-B9A2-43E7-BD25-6368F17ED124

Q28607750-0554980B-4EF7-4506-A0A9-88C14697FD23

Q28607750-0599048B-2FA8-425F-AF0D-CBCF79C80B83

Q28607750-138D3701-BE1F-4968-A35A-1ED27A7CD496

Q28607750-15396897-0613-42AB-AFEC-F70176D0781F

Q28607750-18AD5401-AD84-49EB-90E4-36CDAD72554F

Q28607750-1977ECA2-FCC0-4FC5-8AAB-315A329D5835

Q28607750-19C82F42-B29C-49F6-A90F-C068B19E4526

Q28607750-1AB050ED-2345-4281-9421-6150991432C2

Q28607750-1CEDC7A7-5316-4570-BAAD-3E005F8F42DE

P304

Q28607750-C1885BF7-A563-4010-AAD5-ED0C7494AEF1

P31

Q28607750-51548E37-6BDA-4A96-8698-E9DFA72FC24A

P3181

Q28607750-F3A73135-8EDB-467F-B640-A77DE6132106

P356

Q28607750-47FC7622-2E06-4FB2-B4D2-711AC9944B17

P407

Q28607750-3CD1F1E1-B9F8-4E5F-A923-CAA540433F57

P433

Q28607750-1B4C5FB8-F73E-4679-AE4B-3C9310D31AAF

P478

Q28607750-E9430EAC-CA18-444D-BC12-45FD2AE4AE37

P577

Q28607750-94C59FD2-BE72-46AA-8A6D-DA488609E9FA

P698

Q28607750-30F51877-8D6F-4D75-8DAD-C510276452F0

P921

Q28607750-90EC413F-37AE-4371-8E04-6EA27CCB2B74

Q28607750-AF0093FE-B9F0-41DA-9040-50026B696863

P932

Q28607750-351B06D7-F817-4450-B64B-CEE1E81134EE

P3181

P356

J.MAYOCP.2015.06.013

P1433

Mayo Clinic Proceedings

P1476

Recommendations for Diagnosis, ...... d Nonalcoholic Steatohepatitis

@en

P2093

Erin K Spengler

http://www.w3.org/2001/XMLSchema#string

Rohit Loomba

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

Bariatric surgery for non-alcoholic steatohepatitis in obese patients

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

P304

1233-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2311854

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.MAYOCP.2015.06.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26219858

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

4567478

http://www.w3.org/2001/XMLSchema#string